Multinational corporations are increasingly investing in China's innovative industries and advanced manufacturing, according to HSBC's co-CEO.

In a speech at the 25th China International Fair for Investment and Trade (CIFIT) in Xiamen, Fujian province, David Liao Yi-chien emphasised the global attention being drawn to innovation-driven economic growth in China. Liao, a prominent figure, highlighted China's capital markets as indispensable investment opportunities for international investors.

Liao pointed out that the dynamic innovation ecosystem in China is a key selling point for international investment. He stated that global companies are positioning China as a global market for driving innovation, consumption, and growth. This was evident in the findings of a survey conducted earlier this year, which polled over 5,700 multinational companies (MNCs).

The survey revealed that approximately 40% of the MNCs are increasing or planning to increase their manufacturing in China over the next two years. Furthermore, around 44% of respondents consider China as a primary focus. MNCs remain optimistic about consumption-related industries like fast-moving consumer goods.

Liao stressed that China's comprehensive industrial facilities are a significant draw for foreign investors. He also highlighted China's vast market size as another factor that continues to attract international investment. The continued growth of innovation in China is a key factor in its appeal to international investors, as highlighted by Liao.

Liao also spoke about the abundance of talent in China, which is a factor that attracts international investors. Multinational companies that have increased their investments in sectors such as high technology, healthcare, and pharmaceuticals in China in recent years include PDD Holdings, which continues to invest heavily in its digital commerce ecosystem, and Evernorth Health Services (a subsidiary of The Cigna Group), which made a $3.5 billion investment to expand its presence in specialty medicine, supporting complex and chronic disease care.

China's capital markets are particularly attractive to international investors due to innovation-driven growth, as stated by Liao. This attractiveness was further underlined by the fact that China is the top target market for companies looking to increase their global trade capabilities, according to HSBC's Global Trade Pulse Survey.

In conclusion, Liao's statements at the CIFIT highlight the attractiveness of China's talent pool, dynamic innovation ecosystem, comprehensive industrial facilities, vast market size, and innovation-driven growth to international investors. These factors make China an indispensable destination for international investors seeking opportunities in manufacturing, high-end manufacturing, healthcare, pharmaceuticals, and other sectors.

Multinational corporations are increasingly investing in China's innovative industries and advanced manufacturing, according to HSBC's co-CEO.